ANOREXIA
Clinical trials for ANOREXIA explained in plain language.
Never miss a new study
Get alerted when new ANOREXIA trials appear
Sign up with your email to follow new studies for ANOREXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Antidepressant shows promise for cancer appetite loss
Symptom relief OngoingThis study looks at whether mirtazapine, a drug often used for depression, can improve appetite in people with advanced cancer who are losing weight. About 98 patients will receive either mirtazapine or a placebo for 15 to 29 days. The goal is to see if it helps with appetite, sl…
Matched conditions: ANOREXIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New drug hopes to boost appetite in lung cancer patients
Symptom relief OngoingThis study looks at whether a drug called anamorelin can help improve appetite and stop weight loss in people with advanced non-small cell lung cancer who have lost their appetite. About 25 participants will take either the drug or a placebo and share their experiences through in…
Matched conditions: ANOREXIA
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Can a common mental health drug help cancer patients eat better?
Symptom relief OngoingThis study compares two drugs, olanzapine and megestrol acetate, to see which works better for improving appetite and preventing weight loss in people with advanced cancer. About 227 patients will take one of the two medications for four weeks. The goal is to find a more effectiv…
Matched conditions: ANOREXIA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC